Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients

Journal of Psychiatric Research

Volumn 41, Issue 1-2, 2007, Pages 8-14

  Hänninen, Kari ^a,c,d   Katila, Heikki ^d   Anttila, Sami ^b,c   Rontu, Riikka ^b,c   Maaskola, Julius ^d   Hurme, Mikko ^e   Lehtimäki, Terho ^b,c  

^a SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Association study; EGF; Finnish; Gender; Genetic polymorphism; Schizophrenia

Indexed keywords

5' NUCLEOTIDASE; EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MUTATIONAL ANALYSIS; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

5'-NUCLEOTIDASE; ADOLESCENT; ADULT; AGE OF ONSET; AGED; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENES, ERBB-1; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MESENCEPHALON; MIDDLE AGED; NEURONS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 33750743040     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2005.07.001     Document Type: Article

References (46)

1. Adamson E.D., and Meek J. The ontogeny of epidermal growth factor receptors during mouse development. Developmental Biology 103 (1984) 62-70
2. Alexi T., and Hefti F. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55 (1993) 903-918
3. Anttila S., Illi A., Kampman O., Mattila K.M., Lehtimaki T., and Leinonen E. Association of EGF polymorphism with schizophrenia in Finnish men. Neuroreport 15 (2004) 1215-1218
4. Apostolakis E.M., Garai J., Lohmann J.E., Clark J.H., and O'Malley B.W. Epidermal growth factor activates reproductive behavior independent of ovarian steroids in female rodents. Molecular Endocrinology 14 (2000) 1086-1098
5. Barrie A., Chieregatti E., Miloso M., Benfenati R., and Valtorta F. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes. Molecular Pharmacology 49 (1996) 399-403
6. Bi R., Foy M.R., Thompson R.F., and Baudry M. Effects of estrogen, age, and calpain on MAP kinase and NMDA receptors in female rat brain. Neurobiology of Aging 24 (2003) 977-983
7. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophrenia Bulletin 19 (1993) 431-445
8. Brannvall K., Korhonen L., and Lindholm D. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Molecular and Cellular Neuroscience 21 (2002) 512-520
9. Carlsson M., and Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends in Neurosciences 13 (1990) 272-276
10. Carpenter G., and Cohen S. Epidermal growth factor. Annual Review of Biochemistry 48 (1979) 193-216
11. Casper D., Mytilineou C., and Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. Journal of Neuroscience Research 30 (1991) 372-381
12. Casper D., Roboz G.J., and Blum M. Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture. Journal of Neurochemistry 62 (1994) 2166-2177
13. Conrad A.J., and Scheibel A.B. Schizophrenia and the hippocampus: the embryological hypothesis extended. Schizophrenia Bulletin 13 (1987) 577-587
14. Farkas L.M., and Krieglstein K. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. Journal of Neural Transmission 109 (2002) 267-277
15. Ferrari G., Toffano G., and Skaper S.D. Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: comparison with basic fibroblast growth factor. Journal of Neuroscience Research 30 (1991) 493-497
16. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - clinician version (SCID-I/CV) (1997), American Psychiatric Press, Washington, DC
17. Futamura T., Kakita A., Tohmi M., Sotoyama H., Takahashi H., and Nawa H. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implications for epidermal growth factor in cognitive development. Molecular Psychiatry 8 (2003) 1-5
18. Futamura T., Toyooka K., Iritani S., Niizato K., Nakamura R., Tsuchiya K., Someya T., Kakita A., Takahashi H., and Nawa H. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Molecular Psychiatry 7 (2002) 673-682
19. Gardette R., Rasolonjanahary R., Kordon C., and Enjalbert A. Epidermal growth factor treatment induces D2 dopamine receptors functionally coupled to delayed outward potassium current (IK) in GH4C1 clonal anterior pituitary cells. Neuroendocrinology 59 (1994) 10-19
20. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 158 (2001) 1367-1377
21. Goldstein M., and Deutch A.Y. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB Journal 6 (1992) 2413-2421
22. Kampman O, Anttila S, Illi A, Mattila KM, Rontu R, Leinonen E, Lehtimaki T. Interaction of tumor necrosis factor alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 2004 Dec 24; [Epub ahead of print].
23. Kerwin R.W. Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: a hypothesis. Psychological Medicine 23 (1993) 547-551
24. Koller M.M., Cowman R.A., Humphreys-Beher M.G., and Scarpace P.J. An analysis of submandibular salivary gland function with desipramine and age in female NIA Fischer 344 rats. Mechanisms of Ageing and Development 119 (2000) 131-147
25. Lahti A., Holcomb H., Medoff D., and Tamminga C. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6 (1995) 869-872
26. Lazar L.M., and Blum M. Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-α mRNA in mouse brain by a quantitative nuclease protection assay. Journal of Neuroscience 12 (1992) 1688-1697
27. Lim Y.J., Kim J.W., Song J.Y., Hong M.S., Jin S.Y., Yoon S.H., Park H.J., Choe B.K., Lee J.J., Yim S.V., Hong S.I., Baik H.H., Ha E., and Park Y.H. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neuroscience Letters 374 (2005) 157-160
28. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genetic Analysis: Biomolecular Engineering 14 (1999) 143-149
29. Ma L., Wang W.P., Chow J.Y., Yuen S.T., and Cho C.H. Reduction of EGF is associated with the delay of ulcer healing by cigarette smoking. American Journal of Physiology: Gastrointestinal and Liver Physiology 278 (2000) G10-G17
30. Meador-Woodruff J.H., and Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Research Reviews 31 (2000) 288-294
31. Meltzer H.Y., Rabinowitz J., Lee M.A., Cola P.A., Ranjan R., Findling R.L., and Thompson P.A. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. American Journal of Psychiatry 154 (1997) 475-482
32. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (1988) 1215
33. Missale C., Castelletti L., Boroni F., Memo M., and Spano P. Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line. Endocrinology 128 (1991) 13-20
34. Munemura M., Agui T., and Sibley D.R. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland. Endocrinology 124 (1989) 346-355
35. Nakagawa T., Sasahara M., Hayase Y., Haneda M., Yasuda H., Kikkawa R., Higashiyama S., and Hazama F. Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early postnatal rat. Developmental Brain Research 108 (1998) 263-272
36. Pareja M., Sanchez O., Lorita J., Soley M., and Ramirez I. Activated epidermal growth factor receptor (ErbB1) protects the heart against stress-induced injury in mice. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 285 (2003) R455-R462
37. Pasqualini C., Bojda F., and Kerdelhue B. Direct effect of estradiol on the number of dopamine receptors in the anterior pituitary of ovariectomized rats. Endocrinology 119 (1986) 2484-2489
38. Pezzoli G., Zecchinelli A., Ricciardi S., Burke R.E., Fahn S., Scarlato G., and Carenzi A. Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats. Movement Disorders 6 (1991) 281-287
39. Plata-Salamán C.R. Epidermal growth factor and the nervous system. Peptides 12 (1991) 653-663
40. Seeman P. Schizophrenia as a brain disease. The dopamine receptor story. Archives of Neurology 50 (1993) 1093-1095
41. Seroogy K.B., Lundgren K.H., Lee D.C., Guthrie K.M., and Gall C.M. Cellular localization of transforming growth factor-alpha mRNA in rat forebrain. Journal of Neurochemistry 60 (1993) 1777-1782
42. Shahbazi M., Pravica V., Nasreen N., Fakhoury H., Fryer A.A., Strange R.C., Hutchinson P.E., Osborne J.E., Lear J.T., Smith A.G., and Hutchinson I.V. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359 (2002) 397-401
43. Shelton R.C., Karson C.N., Doran A.R., Pickar D., Bigelow L.B., and Weinberger D.R. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. American Journal of Psychiatry 145 (1988) 154-163
44. Todd R.D. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biological Psychiatry 31 (1992) 794-807
45. Watanabe Y., Fukui N., Muratake T., Kaneko N., and Someya T. No association of EGF polymorphism with schizophrenia in a Japanese population. Neuroreport 16 (2005) 403-405
46. Weinberger D.R. The biological basis of schizophrenia. Journal of Clinical Psychiatry Monograph 15 (1997) 4-6